Names | |
---|---|
Preferred IUPAC name
6-Methoxy-4-[2-(4-{[(2H-[1,3]oxathiolo[5,4-c]pyridin-6-yl)methyl]amino}piperidin-1-yl)ethyl]quinoline-3-carbonitrile | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider |
|
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C25H27N5O2S | |
Molar mass | 461.58 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
GSK 299423orGlaxoSmithKline 299423 is an antibiotic chemical compound that has been identified as potentially effective in treating patients infected with bacteria expressing the New Delhi metallo-beta-lactamase. The antibiotic inhibits the enzyme topoisomerase, which bacteria need to replicate.[1][2][3]
No animal studies have been reported. No application has been made for human clinical trials.[citation needed]
| |||||||
---|---|---|---|---|---|---|---|
Medical microbiology |
| ||||||
Biochemistry and ecology |
| ||||||
Shape |
| ||||||
Structure |
| ||||||
Taxonomy and evolution |
| ||||||
|
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |